Clinical pharmacist practitioner-led clinic improves Helicobacter pylori treatment and eradication testing: A quality improvement initiative

Clicks: 11
ID: 327910
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #238 of 247 articles by views in American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 247 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
PURPOSE: Many patients treated for Helicobacter pylori (HP) do not complete guideline-recommended post-treatment eradication testing. Patients diagnosed via esophagogastroduodenoscopy (EGD) face unique barriers due to fragmented handoffs between providers. We describe the development and early outcomes of a Clinical Pharmacist Practitioner (CPP)-led clinic designed to improve HP management for EGD-diagnosed patients. SUMMARY: We developed a centralized CPP-led clinic to assume responsibility for HP regimen selection, eradication test ordering, and follow-up. The option for referral to this clinic was integrated into an existing EGD results notification workflow for patients with newly diagnosed HP. Comparing a pre-intervention period (October 2022-March 2024, n=105) to a post-intervention period (May 2024-October 2025, n=111), guideline-concordant prescribing increased from 32.4% to 90.8% (p<0.001), testing completion within 6 months increased from 37.1% to 61.3% (adjusted odds ratio 2.88, p<0.001), and eradication among tested patients improved from 82.1% to 92.6%. With extended follow-up, testing completion increased from 62.9% pre-intervention to 84.7% post-intervention (p<0.001), and eventual eradication among those tested increased from 87.9% to 98.9% (p=0.003). CONCLUSION: A centralized CPP-led clinic significantly improved guideline-concordant prescribing, eradication testing completion, and confirmed eradication for EGD-diagnosed HP patients. This scalable model addresses care fragmentation by centralizing the complete care pathway for HP management.
Reference Key
openalex_W7211933191 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Samantha Anne Menegas, Sabrina Layne, Sachiko M. Oshima, Collins Mbonu, Daniel Bernstein, Rachel Britt, Jill Moore, Brian A. Sullivan
Are you one of these authors? Claim your profile
Journal American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists
Year 2026
DOI
10.1093/ajhp/zxag269
URL
https://doi.org/10.1093/ajhp/zxag269
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.